Pancreatitis-associated protein does not predict disease relapse in inflammatory bowel disease patients.
<h4>Background</h4>The pancreatitis-associated protein (PAP) is increased in the serum of active inflammatory bowel disease (IBD) patients and its levels seem to be correlated with disease activity. Our aim was to evaluate the usefulness of serum and fecal PAP measurements to predict rel...
Saved in:
Main Authors: | Tiago Nunes, Maria Josefina Etchevers, Maria Jose Sandi, Susana Pinó Donnay, Teddy Grandjean, Maria Pellisé, Julián Panés, Elena Ricart, Juan Lucio Iovanna, Jean-Charles Dagorn, Mathias Chamaillard, Miquel Sans |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/e0389dc42bc54270b8afa3f8f79ed991 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metalloproteinases in Inflammatory Bowel Diseases
by: Marônek M, et al.
Published: (2021) -
Seminars in inflammatory bowel disease
Published: (2001) - Inflammatory Bowel Disease Monitor
-
MSC therapy for inflammatory bowel disease
by: Mikhail A. Konoplyannikov, et al.
Published: (2021) -
Metabolomics Insights into Inflammatory Bowel Disease: A Comprehensive Review
by: Laila Aldars-García, et al.
Published: (2021)